A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Di Giulio S, Colicchia V, Pastorino F, Pedretti F, et al. Oncogene 2021;40:6143-6152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Giulio S, Colicchia V, Pastorino F, Pedretti F, et al. A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene 2021;40:6143-6152.
PMID: 34508175